Lv1
28 积分 2025-10-28 加入
Imperatorin ameliorates metabolic dysfunction‐associated fatty liver disease through modulating Suv39h1/Fabps/Cept1 signalling pathway
8个月前
已完结
Inflammation and malnutrition in inflammatory bowel disease
8个月前
已完结
Immune checkpoint inhibitors and the liver: balancing therapeutic benefit and adverse events
10个月前
已完结
Harnessing tumor metabolism during cancer treatment: a narrative review of emerging dietary approaches
10个月前
已完结
The altered lipidome of hepatocellular carcinoma
10个月前
已完结
Liver cirrhosis
10个月前
已完结
皖公网安备34019202002308
